MedTrace Logo

Determination of the GI and II Values of Soft Drink and Soft Drink With Sugardown™

NCT03374501 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2017-12-15

No results posted yet for this study

Summary

This study was a partly controlled laboratory-based study comparing the glycemic and insulinemic indices of 3 test meals containing soft drink alone or with SUGARDOWN™ (Galactomannan) in overweight adults.

Conditions

  • Postprandial Hyperglycemia

Interventions

DIETARY_SUPPLEMENT

Sugardown™

Test food #2: 495.0 g Sprite™ soft drink plus 2 Sugardown™ tablet consumed with 250 mL water (repeated twice) Test food #3: 495.0 g Sprite™ soft drink plus 4 Sugardown™ tablet consumed with 250 mL water (repeated twice)

DIETARY_SUPPLEMENT

Soft drink

Test food #1: 495.0 g Sprite™ soft drink consumed with 250 mL water (repeated twice)

Sponsors & Collaborators

  • Boston Therapeutics

    lead INDUSTRY

Principal Investigators

  • Jennie Brand-Miller · School of Molecular Bioscience, University of Syndey, Australia

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2014-12-31
Completion
2014-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03374501 on ClinicalTrials.gov